BioLight Life Sciences Ltd.
BOLT.TA
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.45B
Close$
$54.08
80% downside
Current Fair Value
80% downsideOvervalued by 80% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.45 Billion |
|---|---|
| Enterprise Value | $2.45 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.98 |
| Beta | 0.56 |
| Outstanding Shares | 9,066,962 |
Return
| Return on Equity | -91.95% |
|---|---|
| Return on Assets | -73.67% |
| Return on Invested Capital | -79.63% |
Valuation & Multiples
| P/E Ratio | -2.01 |
|---|---|
| PEG | -944.8 |
| Price to Sales | - |
| Price to Book Ratio | 90.23 |
| Enterprise Value to Revenue | 23355.95 |
| Enterprise Value to EBIT | -94.32 |
| Enterprise Value to Net Income | -95 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BioLight Life Sciences Ltd.
4 employees
CEO: Yaacov Michlin BioLight Life Sciences Ltd. is an ophthalmic firm dedicated to discovering, developing, and bringing to market innovative products and pipeline candidates designed to tackle various eye-related ailments. Its portfolio and development pip...